News Lundbeck trial investigates genetic causes of depression New study with 23andMe and Milken Institute looks to determine causes of depression.
News Lundbeck enlists IBM Watson to aid psychiatric drug research Collaboration will initially focus on Parkinson's disease and schizophrenia.
News Lundbeck epilepsy injection approved in US New carbamazepine formulation when oral dosing not feasible.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
